The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $155,500 in first-year total cost, median $155,500.
Most frequent study sections
- Therapeutic Approaches to Genetic Diseases Study Section[TAG]1
Most frequent institutions
- UNIVERSITY OF WASHINGTON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Urine podocyte and podocyte GL3: novel screening tools for phenotype assessment and treatment efficacy in Fabry disease1R03HD111661-01 | NAJAFIAN, BEHZAD | UNIVERSITY OF WASHINGTON, WA | $155,500 | TAG |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.